Health Care & Life Sciences » Biotechnology | Tissue Regenix Group PLC

Tissue Regenix Group PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
100.00
1,574.20
5,233.00
11,619
Cost of Goods Sold (COGS) incl. D&A
74.00
124.00
183.00
714.50
3,109.00
6,300
Gross Income
74.00
124.00
83.00
859.60
2,124.00
5,319
SG&A Expense
4,383.00
6,459.00
8,259.00
13,050.60
11,578.00
13,530
EBIT
4,457.00
6,583.00
-
12,190.90
9,454.00
8,211
Unusual Expense
-
-
-
-
1,098.00
685
Non Operating Income/Expense
45.00
6.00
27.00
125.50
264.00
55
Pretax Income
3,972.00
6,303.00
8,201.00
11,941.10
10,769.00
8,879
Income Tax
474.00
710.00
620.00
1,128.00
1,348.00
620
Consolidated Net Income
3,498.00
5,593.00
7,581.00
10,813.10
9,421.00
8,259
Net Income
3,498.00
5,593.00
7,581.00
10,675.60
9,221.00
8,186
Net Income After Extraordinaries
3,498.00
5,593.00
7,581.00
10,675.60
9,221.00
8,186
Net Income Available to Common
3,498.00
5,593.00
7,581.00
10,675.60
9,221.00
8,186
EPS (Basic)
0.01
0.01
0.01
0.02
0.01
0.01
Basic Shares Outstanding
635,276.10
635,574.60
636,890.10
760,124.30
920,506.50
1,171,633.40
EPS (Diluted)
0.01
0.01
0.01
0.01
0.01
0.01
Diluted Shares Outstanding
635,276.10
635,574.60
636,890.10
760,124.30
920,506.50
1,171,633.40
EBITDA
4,383.00
6,459.00
8,191.00
11,862.60
8,747.00
7,038
Non-Operating Interest Income
440.00
274.00
168.00
124.40
47.00
72
Minority Interest Expense
-
-
-
137.50
200.00
73

About Tissue Regenix Group

View Profile
Address
Astley Lane Industrial Estate
Leeds Yorkshire LS26 8XT
United Kingdom
Employees -
Website http://tissueregenix.com
Updated 07/08/2019
Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The potential applications of this process address clinical needs such as vascular disease, heart valve replacement and knee repair.